Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-06-11

Clinical Trial Update: Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities

View source ↗

Summary

A clinical trial evaluating Gardasil as therapy for human papillomavirus infection in individuals with low-grade cervical abnormalities has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Eisenhower Army Medical Center | Conditions: Papillomavirus Infections | Status: WITHDRAWN